Our Services
Medical Information
Helpful Resources
Published on: 4/21/2026
Alpha lipoic acid is a potent antioxidant that protects and repairs nerves by neutralizing free radicals, regenerating vitamins C and E, chelating metals, improving microvascular blood flow, reducing inflammation, and enhancing glucose metabolism. This combination stabilizes nerve function, enhances conduction velocity, and can ease diabetic neuropathy symptoms, especially in the feet.
There are several important factors to consider, including optimal dosage, timing, potential side effects, and how ALA integrates into your overall diabetic foot care plan; see below for complete details.
Diabetic peripheral neuropathy—often noticed first in the feet—is a common complication of long-standing high blood sugar. Nerve damage can cause numbness, tingling, burning or shooting pains. Over time, reduced sensation can lead to injuries that go unnoticed, increasing the risk of infections or worse.
Alpha lipoic acid (ALA) is a naturally occurring antioxidant that has been studied for its ability to protect nerves, improve nerve function, and ease symptoms of diabetic neuropathy—especially in the feet. Below is an overview of how ALA works, what the research says, and practical considerations if you or a loved one is exploring ALA for diabetic feet.
• Also called thioctic acid, ALA is found in every cell, where it helps convert nutrients into energy.
• It is both water- and fat-soluble, allowing it to work throughout the body and cross the blood-brain barrier.
• As an antioxidant, it neutralizes free radicals—unstable molecules that damage cells and contribute to aging and disease.
Antioxidant Scavenging
Regeneration of Other Antioxidants
Metal Chelation
Improved Blood Flow
Anti-Inflammatory Effects
Modulation of Glucose Metabolism
While full "regeneration" of severely damaged nerves may be limited, ALA can:
• Stabilize or improve existing nerve fiber function
• Reduce pain intensity and frequency
• Improve nerve conduction velocity (a measure of how fast electrical signals travel along nerves)
• The ORPIL Trial (2006): Intravenous ALA 600 mg/day for three weeks reduced pain by up to 50% in many participants.
• The SYDNEY Trials (2005–2006): Both oral and IV ALA improved positive (burning, shooting) and negative (numbness) neuropathic symptoms.
• NATHAN I (2011) & II (2014) Studies: Long-term oral ALA (600 mg/day) showed sustained improvement in neuropathic symptoms and slowed progression of nerve damage.
Key outcomes reported:
Most clinical trials use:
• Oral ALA 600 mg once daily (often taken on an empty stomach for better absorption)
• Intravenous ALA (600 mg/day) over 3 weeks for more acute symptom relief—usually administered under medical supervision
Important points:
ALA is generally well tolerated. Possible mild side effects include:
• Gastrointestinal upset (nausea, abdominal pain)
• Skin rash or itching
• Headache
Precautions:
Integrate ALA into a broader neuropathy management plan
– Blood sugar control, foot care (daily inspection, proper footwear), physical activity.
Be realistic about timelines
– Symptom improvement may take 4–8 weeks of consistent daily use.
Monitor and record your symptoms
– Use a pain or symptom diary to track changes in tingling, burning, or numbness.
Stay in touch with your healthcare team
– Report any worsening of symptoms, unusual side effects, or changes in glucose readings.
If you experience:
• Open sores or infections on your feet
• Sudden increase in pain or numbness
• Signs of systemic infection (fever, chills)
…you can start by using this free Medically approved LLM Symptom Checker Chat Bot to better understand your symptoms before scheduling urgent care.
This information is intended to help you discuss alpha lipoic acid for diabetic feet with your healthcare provider. If you have life-threatening symptoms, severe infections, or sudden changes in limb sensation, seek immediate medical attention. Always talk to a doctor before starting any supplement, especially if you have multiple health conditions or take other medications.
(References)
* Goya-Godoy R, Zúñiga-Salazar JA, Ortega-Hernández MdP, Pulgarin-Cárdenas NA, Trujillo-Hernández GM. Alpha-Lipoic Acid and Its Protective Effects on Nerve Tissue. *Oxid Med Cell Longev*. 2021;2021:6654157. PMID: 33959247.
* Zhang LH, Ma HM, Zhang YF, Dong YF, Han SM. Alpha-lipoic acid in the treatment of diabetic peripheral neuropathy: a meta-analysis. *Neural Regen Res*. 2020 Feb;15(2):331-337. PMID: 32015243.
* Gürpınar SA, Çekmen B, Yılmaz SE, Güler N, Erdem RS, Erdem G. The Role of Alpha-Lipoic Acid in Nerve Regeneration and Neuroprotection: A Comprehensive Review. *Curr Neuropharmacol*. 2023 Aug 24. doi: 10.2174/1570159X21666230824103138. Epub ahead of print. PMID: 37626359.
* Puranik S, Dindigala C, Chandraiah N. Alpha-Lipoic Acid as a Potential Therapeutic Agent for Neurodegenerative Diseases. *J Biosci Med*. 2022 Mar 31;10(1):1-10. PMID: 35928646.
* Li S, Zhang Y, Ma Q, Zheng M, Li Q, Li H, Hu R, Wang Z, Wu Z, Li S, Zhang P, Liu H. The neuroprotective effect of alpha-lipoic acid on diabetic neuropathy: Current perspectives. *Front Pharmacol*. 2022 Oct 28;13:1044390. PMID: 36387063.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.